GlassHouse Research disclosed that the firm is short Astrana Health (ASTH), arguing in a newly-published report that Astrana’s profit “depends on an unusual stack of management estimates – reserves, PPA marks, ACO settlements, receivables, and adjusted earnings.We think that subjectivity is masking a weaker business.” Astrana shares are down 8% to $34.76 in early trading.
https://www.tipranks.com/news/the-fly/glasshouse-research-says-short-astrana-health-thefly-news
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.